Co., Inc. (NYSE:MRK), a global healthcare leader, declared on Monday a quarterly dividend and a substantial stock repurchase ...

Discover the latest updates on Trinity Health's $800 million Epic EHR rollout, including new features and a delayed timeline, in an interview with Becker's.

The next major content drop for Call of Duty is here, as Treyarch has pushed out Black Ops 6 download version 1.068, which ...

I grabbed Android 16 Beta 1 last week and used it on my Pixel 9 Pro all weekend. It's been smooth sailing — but in my ...

Priority review for Welireg is based on data from the Phase II LITESPARK-015 trial, which showed promising response rates in ...

Patients with metastatic colorectal cancer (mCRC) harboring BRAF V600E mutations benefited from first-line treatment with the ...

The FDA has accepted Merck's (MRK) supplemental NDA with priority review for its drug Welireg for the treatment of a rare ...

The supplemental new drug application is based on data from the Phase 2 LITESPARK-015 trial.

Adagene (ADAG) announced updated clinical data from ADG126 in microsatellite stable colorectal cancer, MSS CRC, at the ASCO Gastrointestinal ...

This important study reveals a role for IκBα in the regulation of embryonic stem cell pluripotency. The solid data in mouse embryonic stem cells include separation of function mutations in IκBα to ...

Shares of Merck & Co. Inc. MRK shed 1.32% to $99.65 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.11% to 5,842.91 ...

Merck & Co., Inc. (NYSE:MRK) is one of the largest pharmaceutical companies in the world. Over the past couple of years, the firm has managed to set itself apart from others primarily through its ...